ArticleBMJ (Clinical research ed.)2000
How many deaths have been avoided through improvements in cancer survival?
Article in BMJ (Clinical research ed.), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 81 citations in OpenAlex.
- Cost-utility analysis of meaning-centered group psychotherapy for cancer survivors.Psycho-oncology · 2018Trial
- Efficacy of meaning-centered group psychotherapy for cancer survivors: a randomized controlled trial.Psychological medicine · 2017Trial
- Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial.BMC psychiatry · 2014Trial
- Cancer and Cardiovascular Disease: The Conjoined Twins.Cancers · 2024Review
- Clinical benefit of anti-PD-(L)1 immunotherapies in advanced cancer in France: a population-based estimate from 2014 to 2021.ESMO open · 2024Article
- Essential cancer medicines and cancer outcomes: Cross-sectional study of 124 countries.Cancer medicine · 2023Article
- The burden of testicular cancer from 1990 to 2019 in the Middle East and North Africa region.Frontiers in oncology · 2023Article
- Sexual and fertility-related adverse effects of medicinal treatment for cancer; a national evaluation among medical oncologists.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Study of Diagnostic Delay among Symptomatic Breast Cancer Patients in Northern India: A Mixed-Methods Analysis from a Dedicated Breast Cancer Centre.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Tumor microenvironment immune-related lncRNA signature for patients with melanoma.Annals of translational medicine · 2021Article
- Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.Lancet (London, England) · 2017Article
- Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10.PloS one · 2016Article
- Melatonin anticancer effects: review.International journal of molecular sciences · 2013Article
- Meaning making in cancer survivors: a focus group study.PloS one · 2013Article
- Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians.Current oncology (Toronto, Ont.) · 2011Article
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.Lancet (London, England) · 2011Article
- What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?British journal of cancer · 2009Article
- Efficacy, safety, and cost of new anticancer drugs. Pessimistic conclusion was not justified.BMJ (Clinical research ed.) · 2002Article
- Women's knowledge and beliefs regarding breast cancer.British journal of cancer · 2002Article
- A qualitative study of delay among women reporting symptoms of breast cancer.The British journal of general practice : the journal of the Royal College of General Practitioners · 2001Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate how many deaths from cancer have been avoided in England and Wales because of recent improvements in survival.
designAnalysis of national statistics.
settingEngland and Wales. SUBJECTS: 1.5 million adults with diagnosis of one of 47 different cancers during 1981-5 or 1986-90.
main outcome measuresReduction in number of cancer deaths within five years of diagnosis among patients with cancer diagnosed during 1986-90 compared with patients with cancer diagnosed during 1981-5.
results17 041 deaths were avoided within five years of diagnosis among patients with cancer diagnosed during 1986-90. This represents 3.3% of the cancer deaths that would have been expected if survival had been the same as for patients with cancer diagnosed during 1981-5. Two thirds of the avoided deaths arose from improvements in survival for just five cancers: female breast cancer (4822), cancers of the colon (2560), rectum (1090), and bladder (1157), and melanoma of the skin (1098). The largest proportionate reductions in excess deaths were for melanoma of the skin (23%) and cancers of the testis (17%) and bone (17%). About 12 000 (70%) of the avoided deaths arose among adults aged under 75 at death. Improvements in survival from cancers of lung, prostate, stomach, ovary, and brain were small: they accounted for 33% of all cancers but only 11% of avoided deaths.
conclusionsSmall gains in survival from common cancers save more lives than larger gains for uncommon cancers. If recent rates of improvement in cancer survival continue, about 24 000 deaths within five years of diagnosis would be avoided in patents aged under 75 by the year 2010, representing about a quarter of the government's overall target of 100 000 fewer cancer deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.